Purchase Order 36C24226P0707

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to CoverMyMeds Pharmacy LLC for the emergency procurement of Pomalyst 3 mg capsules (NDC 59572-0503-21) with a ceiling value of $16,331.35. The contract was awarded on February 26, 2026, with an ultimate completion date of March 5, 2026, reflecting the urgent nature of this pharmaceutical acquisition. The place of performance is located in Memphis, Tennessee. No set-aside...

The Defense Logistics Agency issued a $29,195.26 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Pomalyst 4 mg capsules (21-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Pomalyst 2 mg capsules with a ceiling value of $14,552.44 under a firm fixed-price structure. The order is callable against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place...

Veterans Integrated Service Network 12 issued a $45,210.85 delivery order to Bristol-Myers Squibb Company on January 13, 2026, for supply of REVLIMID, POMALYST, and CAMZYOS specialty pharmaceuticals, with completion required by January 12, 2027. The order is issued under the Department of Veterans Affairs Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award indefinite delivery/indefinite quantity contract with a ceiling value of $12.28 billion extending...

Bristol-Myers Squibb Company was awarded a delivery order valued at $10,887.52 on April 16, 2026, for the supply of POMALYST 3 MG to Veterans Integrated Service Network 5 (VISN 5), with an ultimate completion date of April 23, 2026. This firm fixed-price delivery order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (ID: 36F79724D0101) for Pharmaceuticals and Drugs (FSS-61-IB) with the Department of Veterans Affairs, a master schedule vehicle with a substantial ceiling...

Bristol-Myers Squibb Company has been awarded a delivery order valued at $94,325.50 under its Federal Supply Schedule contract for the supply of Pomalyst (pomalidomide) in multiple dosage strengths (2 mg, 3 mg, and 4 mg formulations) to the Department of Veterans Affairs' Veterans Integrated Service Network 5. This firm fixed-price BPA call order was awarded on February 11, 2026, with an ultimate completion date of February 13, 2026, and will be performed in Memphis, Tennessee. The delivery...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Pomalyst (pomalidomide) 1 mg capsules in quantities of 100 units. This firm fixed price delivery order, valued at $114,147.61, is set to be completed by July 14, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the company's demonstrated...

Bristol-Myers Squibb Company received a delivery order valued at $16,421.95 under its Federal Supply Schedule contract with the Department of Veterans Affairs to supply Pomalyst (pomalidomide) 2mg and 4mg tablets for patient medication to Veterans Integrated Service Network 5, with a completion date of February 25, 2026. This order is issued under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule contract (ID: 36F79724D0101), which carries a substantial ceiling value of $12.28 billion...

Bristol-Myers Squibb Company received a delivery order valued at $138,603.09 under its Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs to supply POMALYST 2 mg and 4 mg tablets to Veterans Integrated Service Network 5, with an ultimate completion date of April 30, 2026. This contract is issued as a firm fixed-price Blanket Purchase Agreement (BPA) call with no set-aside designations and represents a child award under the broader Pharmaceuticals and Drugs (FSS-61-IB)...

Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer, has been awarded a delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 for the supply of Pomalyst (pomalidomide) in 2mg, 3mg, and 4mg formulations to support the Baltimore VA Medical Center. The contract is valued at $138,603.09 on a firm fixed-price basis with a completion date of May 4, 2026. This award represents a call against Bristol-Myers Squibb's existing Federal Supply...